Browse all 0 studies →The Hoffer data →About this project →

Frequently asked questions

What is nicotinic acid (niacin)?

Nicotinic acid, commonly called niacin, is a form of vitamin B3. Unlike niacinamide (nicotinamide), nicotinic acid causes a characteristic skin flush and has distinct therapeutic effects on lipid metabolism and immune modulation.

How does niacin help with autoimmune conditions?

The mechanism is not fully understood, but research points to several pathways: GPR109A receptor activation (an anti-inflammatory receptor on immune cells), NAD+ biosynthesis (restoring cellular energy balance), and gut-immune axis modulation. This site aggregates the evidence across all known pathways.

What is the difference between niacin and niacinamide?

Niacin (nicotinic acid) and niacinamide (nicotinamide) are both forms of vitamin B3, but they have different effects. Niacin activates the GPR109A receptor and causes flushing; niacinamide does not. Research on autoimmune conditions generally focuses on nicotinic acid specifically.

What doses of niacin are used in research?

Therapeutic research on niacin for autoimmune and lipid conditions often uses doses ranging from 1g to 3g per day of nicotinic acid, well above the RDA of 16mg. The Hoffer protocols for orthomolecular medicine used high-dose niacin (1–3g/day) over decades.

Is this site medical advice?

No. Niacin.io is a research aggregator. It organizes published studies and synthesizes evidence pathways. It is not a substitute for medical advice. Always consult a qualified healthcare provider before changing your supplement or medication regimen.